Fed Sparks Profit T...
Health Care: Drugs
Vermillion Inc. (VRML: NASDAQ)
$3.08 0.00 | 0.00%
05/24/13 - 03:59 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -7.15M | -17.79M | -19.03M | -22.05M |
| Operating Gains/Losses | -1.83M | 0.00 | -4.16M | 12.92M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -38.00K | 37.00K | -136.00K | 31.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -2.29M | 253.00K | 63.00K | 4.92M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -143.00K | -1.08M | -3.34M | 0.00 |
| Other Non-Cash Items | 994.00K | 2.46M | 5.94M | 751.00K |
| Net Cash From Continuing Operations | -10.40M | -15.58M | -20.94M | -3.11M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -10.40M | -15.58M | -20.94M | -3.11M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 5.00K | 2.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -14.00K | -99.00K | -180.00K | 0.00 |
| Acquisitions | 1.83M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 60.00K | 40.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 1.82M | -99.00K | 350.00K | 42.00K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 6.00K | 20.24M | 42.82M | 3.65M |
| Repayment of Long-Term Debt | -5.89M | -5.00M | -2.20M | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | -579.00K | 400.00K |
| Net Cash From Financing Activities | -5.89M | 15.24M | 40.05M | 4.05M |
| Effect of Exchange Rate Changes | 0.00 | 3.00K | 9.00K | -3.00K |
| Net Change in Cash & Cash Equivalents | -14.47M | -437.00K | 19.47M | 976.00K |
Portfolios with VRML
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Drug Stock Losers of 2010
- UserDNC Portfolio 1
Latest VRML Headlines from TheStreet
- Vermillion Management Discusses Q2 2012 Results - Earnings Call Transcript 08.14.12 | 07:08 pm
- 7 Stocks Under $10 Soaring Higher 05.24.12 | 12:05 pm
- 7 Stocks Soaring in a Weak Market 05.08.12 | 02:05 pm
- 8 Stocks Under $10 Making Big Moves 04.24.12 | 12:04 pm
- 7 Stocks Under $10 Moving Higher 11.16.11 | 12:11 pm
- 5 Drug Stock Losers of 2010 12.06.10 | 07:12 am
- Best and Worst Drug Stocks in Q3 10.01.10 | 08:10 am
- Biotech Stock Mailbag - Second Quarter Updates 08.13.10 | 07:08 am
Press Releases for VRML
- Vermillion Announces Closing Of Equity Financing - PR Newswire 05.14.13 | 08:05 am
- Vermillion Announces Equity Financing - PR Newswire 05.09.13 | 08:05 am
- Vermillion Supports First World Ovarian Cancer Day And Effort To Raise Awareness Of The Need For Better Diagnosis And Treatment - PR Newswire 05.08.13 | 04:05 pm
- Vermillion Sets First Quarter 2013 Conference Call For Wednesday, May 15, 2013 - PR Newswire 05.01.13 | 08:05 am
- U.S. Army And Vermillion To Assess Health And Economic Benefits Of OVA1 As A Standard Of Care - PR Newswire 04.17.13 | 08:04 am
- Vermillion Appoints Bruce A. Huebner To Chairman Of The Board - PR Newswire 03.19.13 | 08:03 am
- Vermillion Appoints Thomas McLain As President And Chief Executive Officer - PR Newswire 03.13.13 | 08:03 am
- Vermillion To Report Results For Fourth Quarter And Full Year 2012 On Wednesday, February 20, 2013 - PR Newswire 02.19.13 | 10:02 am
- Vermillion To Participate In Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference On February 27, 2013 - PR Newswire 02.19.13 | 08:02 am
- Vermillion To Discuss Preliminary Results For Fourth Quarter And Full Year 2012 On Wednesday, February 20, 2013, At 4:30 P.m. ET - PR Newswire 02.08.13 | 08:02 am
Partner Headlines for VRML
- Mid-Day Market Losers - Benzinga 05.25.12 | 01:05 pm
- Morning Market Movers - Benzinga 03.27.12 | 09:03 am
- Mid-Sized Canadian Oil and Gas Companies Show How Hedging Pays Off - Seeking Alpha 07.21.11 | 09:07 am
- Top Percentage Gainers and Losers as of 2pm 05/13/11 (ABIO, GFRE, DDS, APL, DF, VRML, DAR, SWSH, ONTY, GS, RMBS, LPHI, GGS, CA, NVDA, IMRS, MNTX, MPG, GTY) - Benzinga 05.13.11 | 02:05 pm
- Vermillion Shares Climb 9% (VRML) - Benzinga 01.11.11 | 01:01 pm
- Vermillion Trading Up 27.47% Today (VRML) - Benzinga 12.27.10 | 01:12 pm
